Mucosal vaccines: high-tech reagents for low-tech immunization

Claude P. Muller

doi:10.1016/0167-5699(94)90188-0

Mucosal vaccines: high-tech reagents for low-tech immunization

Claude P. Muller^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

6 Citations (Scopus)

Abstract

Antigens are usually poorly immunogenic when administered orally or intranasally and a variety of approaches have been designed to overcome this problem. Recently, the progress of six projects involving 24 laboratories funded by the 'Human and Veterinary Vaccines' section of the EC-Biotechnology programme were discussed at a meeting in Luxembourg.

Original language	English
Pages (from-to)	458-459
Number of pages	2
Journal	Immunology Today
Volume	15
Issue number	10
DOIs	https://doi.org/10.1016/0167-5699(94)90188-0
Publication status	Published - Oct 1994
Externally published	Yes

Access to Document

10.1016/0167-5699(94)90188-0

Cite this

@article{5a9f5abc60ba4e4ba82f41e2f48c5a38,

title = "Mucosal vaccines: high-tech reagents for low-tech immunization",

abstract = "Antigens are usually poorly immunogenic when administered orally or intranasally and a variety of approaches have been designed to overcome this problem. Recently, the progress of six projects involving 24 laboratories funded by the 'Human and Veterinary Vaccines' section of the EC-Biotechnology programme were discussed at a meeting in Luxembourg.",

author = "Muller, {Claude P.}",

year = "1994",

month = oct,

doi = "10.1016/0167-5699(94)90188-0",

language = "English",

volume = "15",

pages = "458--459",

journal = "Immunology Today",

issn = "0167-5699",

publisher = "Elsevier Ltd.",

number = "10",

}

TY - JOUR

T1 - Mucosal vaccines

T2 - high-tech reagents for low-tech immunization

AU - Muller, Claude P.

PY - 1994/10

Y1 - 1994/10

N2 - Antigens are usually poorly immunogenic when administered orally or intranasally and a variety of approaches have been designed to overcome this problem. Recently, the progress of six projects involving 24 laboratories funded by the 'Human and Veterinary Vaccines' section of the EC-Biotechnology programme were discussed at a meeting in Luxembourg.

AB - Antigens are usually poorly immunogenic when administered orally or intranasally and a variety of approaches have been designed to overcome this problem. Recently, the progress of six projects involving 24 laboratories funded by the 'Human and Veterinary Vaccines' section of the EC-Biotechnology programme were discussed at a meeting in Luxembourg.

UR - http://www.scopus.com/inward/record.url?scp=43949160977&partnerID=8YFLogxK

U2 - 10.1016/0167-5699(94)90188-0

DO - 10.1016/0167-5699(94)90188-0

M3 - Article

C2 - 7945768

AN - SCOPUS:43949160977

SN - 0167-5699

VL - 15

SP - 458

EP - 459

JO - Immunology Today

JF - Immunology Today

IS - 10

ER -

Mucosal vaccines: high-tech reagents for low-tech immunization

Abstract

Access to Document

Other files and links

Fingerprint

Cite this